Immutep (IMMP) Receivables - Other (2014 - 2021)

Immutep (IMMP) posted Receivables - Other of $1.4 million for Q4 2021, down 99.98% on a QoQ basis from $6.0 billion in Q4 2014.

Immutep (IMMP) Receivables - Other (2014 - 2021) Analysis & Trends

Immutep's Receivables - Other history runs 2 years deep, the most recent figure standing at $1.4 million for Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Immutep	569.08 Mn	569.08 Mn	-

Download Data